EFFICACY AND SAFETY OF MOMELOTINIB COMBINED WITH TRAMETINIB IN ADULTS WITH METASTATIC KRAS-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC) WHO HAVE FAILED PLATINUM-BASED CHEMOTHERAPY PRECEDED BY A DOSE-FINDING LEAD-IN PHASE: